Impending Low Intake Dehydration at Admission to A Geriatric Ward- Prevalence and Correlates in a Cross-Sectional Study
Abstract
1. Introduction
2. Materials and Methods
2.1. Study Parameters
2.2. Statistical Analysis
2.3. Ethics Approval
3. Results
4. Discussion
5. Conclusions
Funding
Acknowledgments
Conflicts of Interest
Abbreviations
References
- Molaschi, M.; Ponzetto, M.; Massaia, M.; Villa, L.; Scarafiotti, C.; Ferrario, E. Hypernatremic dehydration in the elderly on admission to hospital. J. Nutr. Health. Aging. 1997, 1, 156–160. [Google Scholar] [PubMed]
- Warren, J.L.; Bacon, W.E.; Harris, T.; McBean, A.M.; Foley, D.J.; Phillips, C. The burden and outcomes associated with dehydration among US elderly, 1991. Am. J. Public. Health. 1994, 84, 1265–1269. [Google Scholar] [CrossRef] [PubMed]
- Morley, J.E. Dehydration, Hypernatremia, and Hyponatremia. Clin. Geriatr. Med. 2015, 31, 389–399. [Google Scholar] [CrossRef] [PubMed]
- Lavizzo-Mourey, R.J. Dehydration in the elderly: A short review. J. Natl. Med. Assoc. 1987, 79, 1033–1038. [Google Scholar] [PubMed]
- Koch, C.A.; Fulop, T. Clinical aspects of changes in water and sodium homeostasis in the elderly. Rev. Endocr. Metab. Disord. 2017, 18, 49–66. [Google Scholar] [CrossRef] [PubMed]
- Phillips, P.A.; Bretherton, M.; Johnston, C.I.; Gray, L. Reduced osmotic thirst in healthy elderly men. Am. J. Physiol. 1991, 261, R166–R171. [Google Scholar] [CrossRef]
- Dharmarajan, K.; Swami, S.; Gou, R.Y.; Jones, R.N.; Inouye, S.K. Pathway from Delirium to Death: Potential In-Hospital Mediators of Excess Mortality. J. Am. Geriatr. Soc. 2017, 65, 1026–1033. [Google Scholar] [CrossRef]
- Magny, E.; Le Petitcorps, H.; Pociumban, M.; Bouksani-Kacher, Z.; Pautas, E.; Belmin, J.; Bastuji-Garin, S.; Lafuente-Lafuente, C. Predisposing and precipitating factors for delirium in community-dwelling older adults admitted to hospital with this condition: A prospective case series. PLoS ONE 2018, 13, e0193034. [Google Scholar] [CrossRef]
- Manabe, T.; Teramoto, S.; Tamiya, N.; Okochi, J.; Hizawa, N. Risk Factors for Aspiration Pneumonia in Older Adults. PLoS ONE 2015, 10, e0140060. [Google Scholar] [CrossRef]
- Feehally, J.; Khosravi, M. Effects of acute and chronic hypohydration on kidney health and function. Nutr. Rev. 2015, 73, 110–119. [Google Scholar] [CrossRef]
- Doherty, K.; Archambault, E.; Kelly, B.; Rudolph, J.L. Delirium markers in older fallers: A case-control study. Clin. Interv. Aging. 2014, 9, 2013–2018. [Google Scholar] [CrossRef] [PubMed]
- Moudouni, D.K.; Phillips, C.D. In-hospital mortality and unintentional falls among older adults in the United States. J. Appl. Gerontol. 2013, 32, 923–935. [Google Scholar] [CrossRef] [PubMed]
- Thomas, D.R.; Tariq, S.H.; Makhdomm, S.; Haddad, R.; Moinuddin, A. Physician misdiagnosis of dehydration in older adults. J. Am. Med. Dir. Assoc. 2004, 5, S30–S34. [Google Scholar] [CrossRef]
- Bennett, J.A.; Thomas, V.; Riegel, B. Unrecognized chronic dehydration in older adults: Examining prevalence rate and risk factors. J. Gerontol. Nurs. 2004, 30, 22–28. [Google Scholar] [CrossRef]
- Shimizu, M.; Kinoshita, K.; Hattori, K.; Ota, Y.; Kanai, T.; Kobayashi, H.; Tokuda, Y. Physical signs of dehydration in the elderly. Intern. Med. 2012, 51, 1207–1210. [Google Scholar] [CrossRef]
- Bunn, D.K.; Hooper, L. Signs and Symptoms of Low-Intake Dehydration Do Not Work in Older Care Home Residents-DRIE Diagnostic Accuracy Study. J. Am. Med. Dir. Assoc. 2019, 20, 963–970. [Google Scholar] [CrossRef]
- Frangeskou, M.; Lopez-Valcarcel, B.; Serra-Majem, L. Dehydration in the Elderly: A Review Focused on Economic Burden. J. Nutr. Health. Aging. 2015, 19, 619–627. [Google Scholar] [CrossRef]
- Cheuvront, S.N.; Ely, B.R.; Kenefick, R.W.; Sawka, M.N. Biological variation and diagnostic accuracy of dehydration assessment markers. Am. J. Clin. Nutr. 2010, 92, 565–573. [Google Scholar] [CrossRef]
- Hooper, L.; Abdelhamid, A.; Ali, A.; Bunn, D.K.; Jennings, A.; John, W.G.; Kerry, S.; Lindner, G.; Pfortmueller, C.A.; Sjostrand, F. Diagnostic accuracy of calculated serum osmolarity to predict dehydration in older people: Adding value to pathology laboratory reports. BMJ. Open. 2015, 5, e008846. [Google Scholar] [CrossRef]
- Siervo, M.; Bunn, D.; Prado, C.M.; Hooper, L. Accuracy of prediction equations for serum osmolarity in frail older people with and without diabetes. Am. J. Clin. Nutr. 2014, 100, 867–876. [Google Scholar] [CrossRef]
- Volkert, D.; Beck, A.M.; Cederholm, T.; Cruz-Jentoft, A.; Goisser, S.; Hooper, L.; Kiesswetter, E.; Maggio, M.; Raynaud-Simon, A.; Sieber, C.C. ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin. Nutr. 2019, 38, 10–47. [Google Scholar] [CrossRef] [PubMed]
- Wojszel, Z.B.; Magnuszewski, L.; Swietek, M.; Kasiukiewicz, A.; Swietek, M.L.; Zubrewicz, K. Frailty syndrome and functional correlates of atrial fibrillation in patients admitted to the geriatric ward. Gerontology. Pol. 2019, 27, 11–15. [Google Scholar]
- Wojszel, Z.B.; Kasiukiewicz, A.; Magnuszewski, L. Health and Functional Determinants of Orthostatic Hypotension in Geriatric Ward Patients: A Retrospective Cross Sectional Cohort Study. J. Nutr. Health. Aging. 2019, 23, 509–517. [Google Scholar] [CrossRef] [PubMed]
- Khajuria, A.; Krahn, J. Osmolality revisited--deriving and validating the best formula for calculated osmolality. Clin. Biochem. 2005, 38, 514–519. [Google Scholar] [CrossRef] [PubMed]
- Mahoney, F.I.; Barthel, D.W. Functional Evaluation: The Barthel Index. Md. State. Med. J. 1965, 14, 61–65. [Google Scholar]
- Fillenbaum, G.G.; Smyer, M.A. The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J. Gerontol. 1981, 36, 428–434. [Google Scholar] [CrossRef]
- Hodkinson, H.M. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age. Ageing. 1972, 1, 233–238. [Google Scholar] [CrossRef]
- Yesavage, J.A.; Brink, T.L.; Rose, T.L.; Lum, O.; Huang, V.; Adey, M.; Leirer, V.O. Development and validation of a geriatric depression screening scale: A preliminary report. J. Psychiatr. Res. 1982, 17, 37–49. [Google Scholar] [CrossRef]
- Tinetti, M.E. Performance-oriented assessment of mobility problems in elderly patients. J. Am. Geriatr. Soc. 1986, 34, 119–126. [Google Scholar] [CrossRef]
- Podsiadlo, D.; Richardson, S. The timed “Up & Go”: A test of basic functional mobility for frail elderly persons. J. Am. Geriatr. Soc. 1991, 39, 142–148. [Google Scholar]
- Norton, D.; McLaren, R. Exton-Smith AN: An Investigation of Geriatric Nursing Problems in Hospital; Churchill Livingstone: Edinburgh, UK; New York, NY, USA, 1975. [Google Scholar]
- Kaiser, M.J.; Bauer, J.M.; Ramsch, C.; Uter, W.; Guigoz, Y.; Cederholm, T.; Thomas, D.R.; Anthony, P.; Charlton, K.E.; Maggio, M. Validation of the Mini Nutritional Assessment short-form (MNA-SF): A practical tool for identification of nutritional status. J. Nutr. Health. Aging. 2009, 13, 782–788. [Google Scholar] [CrossRef] [PubMed]
- Levey, A.S.; Stevens, L.A.; Schmid, C.H.; Zhang, Y.L.; Castro, A.F., 3rd; Feldman, H.I.; Kusek, J.W.; Eggers, P.; Van Lente, F.; Greene, T. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 2009, 150, 604–612. [Google Scholar] [CrossRef] [PubMed]
- Rockwood, K.; Song, X.; MacKnight, C.; Bergman, H.; Hogan, D.B.; McDowell, I.; Mitnitski, A. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005, 173, 489–495. [Google Scholar] [CrossRef] [PubMed]
- Cruz-Jentoft, A.J.; Bahat, G.; Bauer, J.; Boirie, Y.; Bruyere, O.; Cederholm, T.; Cooper, C.; Landi, F.; Rolland, Y.; Sayer, A.A. Sarcopenia: Revised European consensus on definition and diagnosis. Age. Ageing. 2019, 48, 16–31. [Google Scholar] [CrossRef]
- Stookey, J.D. High prevalence of plasma hypertonicity among community-dwelling older adults: Results from NHANES III. J. Am. Diet. Assoc. 2005, 105, 1231–1239. [Google Scholar] [CrossRef]
- Namasivayam-MacDonald, A.M.; Slaughter, S.E.; Morrison, J.; Steele, C.M.; Carrier, N.; Lengyel, C.; Keller, H.H. Inadequate fluid intake in long term care residents: Prevalence and determinants. Geriatric. Nursing. 2018, 39, 330–335. [Google Scholar] [CrossRef]
- Hooper, L.; Bunn, D.K.; Downing, A.; Jimoh, F.O.; Groves, J.; Free, C.; Cowap, V.; Potter, J.F.; Hunter, P.R.; Shepstone, L. Which Frail Older People Are Dehydrated? The UK DRIE Study. J. Gerontol. A. Biol. Sci. Med. Sci. 2016, 71, 1341–1347. [Google Scholar] [CrossRef]
- Lavizzo-Mourey, R.; Johnson, J.; Stolley, P. Risk factors for dehydration among elderly nursing home residents. J. Am. Geriatr. Soc. 1988, 36, 213–218. [Google Scholar] [CrossRef]
- Stookey, J.D.; Purser, J.L.; Pieper, C.F.; Cohen, H.J. Plasma hypertonicity: Another marker of frailty? J. Am. Geriatr. Soc. 2004, 52, 1313–1320. [Google Scholar] [CrossRef]
- Stookey, J.D.; Barclay, D.; Arieff, A.; Popkin, B.M. The altered fluid distribution in obesity may reflect plasma hypertonicity. Eur. J. Clin. Nutr. 2007, 61, 190–199. [Google Scholar] [CrossRef]
- Kurniawan, A.L.; Hsu, C.Y.; Rau, H.H.; Lin, L.Y.; Chao, J.C. Association of kidney function-related dietary pattern, weight status, and cardiovascular risk factors with severity of impaired kidney function in middle-aged and older adults with chronic kidney disease: A cross-sectional population study. Nutr. J. 2019, 18, 27. [Google Scholar] [CrossRef] [PubMed]
- Islam, T.M.; Fox, C.S.; Mann, D.; Muntner, P. Age-related associations of hypertension and diabetes mellitus with chronic kidney disease. BMC Nephrol. 2009, 10, 17. [Google Scholar] [CrossRef] [PubMed]
- Kaewput, W.; Thongprayoon, C.; Varothai, N.; Sirirungreung, A.; Rangsin, R.; Bathini, T.; Mao, M.A.; Cheungpasitporn, W. Prevalence and associated factors of hospitalization for dysglycemia among elderly type 2 diabetes patients: A nationwide study. World. J. Diabetes. 2019, 10, 212–223. [Google Scholar] [CrossRef]
- Distler, A.; Keim, H.J.; Philipp, T.; Philippi, A.; Walter, U.; Werner, E. [Exchangeable sodium, total-body potassium, plasma volume, and hypotensive effect of various diuretics in patients with essential hypertension and low plasma renin level (author’s transl)]. Dtsch. Med. Wochenschr. 1974, 99, 864–869. [Google Scholar]
- Wambach, G.; Schittenhelm, U.; Stimpel, M.; Bonner, G.; Kaufmann, W. Natriuretic action of ANP is blunted by ACE inhibition in humans. J. Cardiovasc. Pharmacol. 1989, 13, 748–753. [Google Scholar] [CrossRef]
- Shepshelovich, D.; Schechter, A.; Calvarysky, B.; Diker-Cohen, T.; Rozen-Zvi, B.; Gafter-Gvili, A. Medication-induced SIADH: Distribution and characterization according to medication class. Br. J. Clin. Pharmacol. 2017, 83, 1801–1807. [Google Scholar] [CrossRef]
- Akhmedov, K.; Rizzo, V.; Kadakkuzha, B.M.; Carter, C.J.; Magoski, N.S.; Capo, T.R.; Puthanveettil, S.V. Decreased response to acetylcholine during aging of aplysia neuron R15. PLoS ONE 2013, 8, e84793. [Google Scholar] [CrossRef][Green Version]
- Bialecka-Debek, A.; Pietruszka, B. The association between hydration status and cognitive function among free-living elderly volunteers. Aging. Clin. Exp. Res. 2019, 31, 695–703. [Google Scholar] [CrossRef]
All | Dehydration+ | Dehydration- | p1 | Missing Values | |
---|---|---|---|---|---|
n (%) | 358 (100.0) | 209 (58.4) | 149 (41.6) | ||
Sociodemographic parameters | |||||
Age (y), Mdn (IQR) | 82 (78–86) | 82 (78–86) | 82 (77–86) | 0.33 | |
Age (75+), n (%) | 309 (86.3) | 185 (88.5) | 124 (83.2) | 0.16 | - |
Sex (F), n (%) | 274 (76.5) | 161 (77.0) | 113 (75.8) | 0.80 | - |
Residence (rural), n (%) | 77 (21.5) | 45 (21.5) | 32 (21.59) | 1.00 | - |
Living in long term care, n (%) | 11 (3.1) | 7 (3.3) | 4 (2.7) | 1.0 | - |
Living alone, n (%) | 105 (30.3) | 64 (31.7) | 41 (28.3) | 0.55 | 11 |
Health parameters | |||||
Hospitalizations in the last year, n (%) | 98 (27.6) | 55 (26.6) | 43 (29.1) | 0.63 | 3 |
Chronic diseases, Mdn (IQR) | 5.0 (3.0–6.0) | 5.0 (4.0–6.0) | 4.0 (3.0–6.0) | 0.001 | |
Multimorbidity, n (%) | 210 (58.7) | 134 (64.1) | 76 (51.0) | 0.02 | - |
Parkinson disease, n (%) | 51 (14.2) | 29 (13.9) | 22 (14.8) | 0.88 | - |
Dementia, n (%) | 122 (34.1) | 69 (33.0) | 53 (35.6) | 0.65 | - |
Depression, n (%) | 154 (55.8) | 87 (53.0) | 67 (59.8) | 0.27 | 82 |
Ischemic heart disease, n (%) | 191 (53.4) | 121 (57.9) | 70 (47.0) | 0.05 | - |
Chronic cardiac failure, n (%) | 141 (39.4) | 90 (43.1) | 51 (34.2) | 0.10 | - |
NYHA class I/II, n (%) | 70 (49.6) | 44 (48.9) | 26 (51.0) | 0.86 | |
NYHA class III/IV, n (%) | 71 (50.4) | 46 (51.1) | 25 (49.0) | ||
Atrial fibrillation, n (%) | 88 (24.6) | 52 (24.9) | 36 (24.2) | 0.90 | - |
Myocardial infarction, n (%) | 35 (9.8) | 24 (11.5) | 11 (7.4) | 0.21 | - |
Peripheral arterial disease, n (%) | 57 (15.9) | 32 (15.3) | 25 (16.8) | 0.77 | - |
Diabetes, n (%) | 108 (30.2) | 76 (36.4) | 32 (21.5) | 0.002 | - |
Hypertension, n (%) | 278 (77.7) | 176 (84.2) | 102 (68.5) | 0.001 | - |
Stroke/ TIA, n (%) | 52 (14.5) | 30 (14.4) | 22 (14.8) | 1.00 | - |
Neoplasm, n (%) | 31 (8.7) | 16 (7.7) | 15 (10.1) | 0.45 | - |
Osteoarthritis, n (%) | 277 (77.4) | 164 (78.5) | 113 (75.8) | 0.61 | - |
Osteoporosis, n (%) | 56 (15.6) | 30 (14.4) | 26 (17.4) | 0.46 | - |
Chronic kidney disease, n (%) | 191 (53.4) | 133 (63.6) | 58 (38.9) | <0.001 | - |
Urinary incontinence, n (%) | 171 (47.9) | 102 (48.8) | 69 (46.6) | 0.75 | 1 |
Systolic BP, mmHg, Mdn (IQR) | 130 (120–140) | 130 (120–140) | 130 (120–140) | 0.28 | 3 |
Diastolic BP, mmHg, Mdn (IQR) | 70 (60–80) | 70 (60–80) | 70 (60–80) | 0.55 | 3 |
Orthostatic hypotension, n (%) | 50 (16.1) | 27 (15.0 | 23 (17.7) | 0.54 | 48 |
Biochemical parameters | |||||
Osmolarity, mMol/L, Mdn (IQR) | 296.5 (292.2–299.6) | 298.9 (296.9–301.6) | 291.1 (287.3–293.3) | <0.001 | - |
Serum sodium, mmol/L, Mdn (IQR) | 140.0 (138.0–141.0) | 141.0 (140.0–142.0) | 138.0 (136.0–139.0) | <0.001 | - |
Hyponatremia, n (%) | 24 (6.7) | 4 (1.9) | 20 (13.4) | <0.001 | - |
Serum potassium, mmol/L, M(SD) | 4.43 (0.46) | 4.50 (0.46) | 4.33 (0.44) | 0.001 | - |
Serum urea, mmol/L, Mdn (IQR) | 6.9 (5.5–8.8) | 7.8 (6.2–9.9) | 5.8 (4.9–7.3) | <0.001 | - |
Fasting glucose, mmol/L, Mdn (IQR) | 5.5 (5.0–6.3) | 5.6 (5.2–6.7) | 5.3 (4.9–5.8) | <0.001 | - |
>7.8mmol/L, n (%) | 43 (12.0) | 36 (17.2) | 7 (4.7) | <0.001 | |
>10mmol/L, n (%) | 12 (3.6) | 10 (4.9) | 2 (1.6) | 0.14 | |
Serum calcium, mmol/L, M (SD) | 1.14 (0.07) | 1.15 (0.07) | 1.13 (0.06) | 0.14 | 84 |
eGFR, ml/min/1.73m2, M (SD) | 57.8 (17.1) | 58.2 (16.8) | 58.4 (16.7) | 0.91 | 4 |
Serum creatinine, mmol/L, Mdn (IQR) | 86.2 (74.3–107.2) | 91.05 (77.8–115.8) | 78.7 (69.8–96.4) | <0.001 | 4 |
Hemoglobin, mmol/L, M (SD) | 7.76 (1.08) | 7.75 (1.08) | 7.79 (1.08) | 0.70 | 3 |
Anemia, n (%) | 158 (44.5) | 92 (44.7) | 66 (44.3) | 1.0 | 3 |
Medications | |||||
Number of medications, Mdn (IQR) | 7.0 (5.0–9.0) | 7.0 (5.0–10.0) | 7.0 (4.0–9.0) | 0.01 | 8 |
Polypharmacy, n (%) | 275 (78.6) | 172 (83.5) | 103 (71.5) | 0.008 | 8 |
Alfa1-blockers, n (%) | 21 (6.0) | 13 (6.3) | 8 (5.6) | 0.82 | 9 |
Neuroleptics, n (%) | 63 (18.1) | 34 (16.6) | 29 (20.1) | 0.40 | 9 |
ACE-I/ ARB, n (%) | 219 (62.8) | 138 (67.3) | 81 (56.3) | 0.04 | 9 |
Procognitive medications, n (%) | 45 (12.9) | 20 (9.8) | 25 (17.4) | 0.05 | 9 |
AChE-I, n (%) | 40 (11.5) | 18 (8.8) | 22 (15.3) | 0.09 | 9 |
Memantine, n (%) | 13 (3.7) | 4 (2.0) | 9 (6.3) | 0.046 | 9 |
Donepezil, n (%) | 26 (7.4) | 13 (6.3) | 13 (9.0) | 0.41 | 9 |
Rivastigmine, n (%) | 14 (4.0) | 5 (2.4) | 9 (6.3) | 0.097 | 9 |
Calcium channel blockers, n (%) | 96 (27.5) | 58 (28.3) | 38 (26.4) | 0.72 | 9 |
Beta-blockers, n (%) | 223 (63.9) | 141 (68.8) | 82 (56.9) | 0.03 | 9 |
Digoxin, n (%) | 27 (7.7) | 17 (8.3) | 10 (6.9) | 0.69 | 9 |
Diuretics, n (%) | 166 (47.6) | 110 (53.7) | 56 (38.9) | 0.009 | 9 |
Lipid lowering drugs, n (%) | 117 (33.5) | 78 (38.0) | 39 (27.1) | 0.04 | 9 |
Benzodiazepines, n (%) | 41 (11.7) | 24 (11.7) | 17 (11.8) | 1.00 | 8 |
SSRI, n (%) | 97 (27.8) | 49 (23.9) | 48 (33.3) | 0.07 | 9 |
NSAIDs, n (%) | 21 (6.0) | 14 (6.8) | 7 (4.9) | 0.50 | 9 |
All | Dehydration+ | Dehydration- | p1 | Missing Values | |
---|---|---|---|---|---|
n (%) of patients | 358 (100.0) | 209 (58.4) | 149 (41.6) | ||
Functional parameters | |||||
Barthel Index, Mdn (IQR) | 90 (70–100) | 90 (70–100) | 90 (65–100) | 0.48 | 2 |
IADL, Mdn (IQR) | 7.0 (2.0–11.0) | 7.0 (2.0–11.0) | 7.0 (1.75–11.0) | 0.55 | 6 |
AMTS, Mdn (IQR) | 8.0 (6.0–9.0) | 8.0 (6.0–9.0) | 8.0 (6.0–9.0) | 0.88 | 26 |
GDS, Mdn (IQR) | 6.5 (3.0–10.0) | 6.0 (3.0–10.0) | 7.0 (4.0–10.0) | 0.32 | 38 |
Handgrip, kg, M (SD) | 18.9 (7.4) | 18.93 (7.5) | 18.97 (7.3) | 0.96 | 55 |
man (n = 68) | 26.3 (8.6) | 26.8 (9.3) | 25.7 (7.8) | 0.61 | 16 |
woman (n = 235) | 16.8 (5.5) | 16.9 (5.3) | 16.7 (5.7) | 0.86 | 39 |
Sarcopenia, n (%) | 140 (46.2) | 80 (46.0) | 60 (46.5) | 1.0 | 55 |
Gait speed, m/s, M (SD) | 0.68 (0.34) | 0.60 (0.37) | 0.69 (0.35) | 0.65 | 88 |
Gait speed ≤ 0.8 m/s, n (%) | 176 (65.2) | 110 (69.2) | 66 (59.5) | 0.12 | 88 |
POMA score, Mdn (IQR) | 23.0 (17.3–28.0) | 23.0 (18.0–28.0) | 23.0 (16.8–28.0) | 0.92 | 78 |
POMA < 19 points, n (%) | 81 (28.9) | 47 (29.0) | 34 (28.8) | 1.00 | 78 |
TUG, s, Mdn (IQR) | 17.4 (12.0–28.1) | 18.9 (12.4–28.0) | 16.6 (11.7–28.4) | 0.68 | 97 |
TUG ≥ 20 s, n (%) | 110 (42.1) | 69 (45.1) | 41 (38.0) | 0.26 | 97 |
Falls in the last 12 months, n (%) | 144 (46.6) | 80 (44.9) | 64 (48.9) | 0.56 | 49 |
CFS, Mdn (IQR) | 5.0 (4.0–6.0) | 5.0 (4.0–6.0) | 5.0 (4.0–5.5) | 0.69 | - |
Severe frailty, n (%) | 91 (25.4) | 54 (25.8) | 37 (24.8) | 0.90 | - |
Norton scale score, Mdn (IQR) | 17.0 (15.0–19.0) | 17.0 (15.0–19.0) | 17.0 (15.0–19.0) | 0.64 | 2 |
Nutritional parameters | |||||
BMI, kg/m2, M (SD) | 29.0 (6.0) | 29.8 (6.2) | 28.1 (5.6) | 0.01 | 55 |
BMI < 24 kg/m2, n (%) | 59 (19.5) | 32 (18.3) | 27 (21.1) | 0.56 | 55 |
BMI > 30 kg/m2, n (%) | 124 (40.9) | 81 (46.3) | 43 (33.6) | 0.03 | 55 |
Albumin, g/L, M (SD) | 38.9 (3.8) | 39.2 (3.7) | 38.5 (4.0) | 0.11 | 11 |
Albumin < 35 g/L | 54 (15.6) | 29 (14.5) | 25 (17.0) | 0.55 | 11 |
MNA-SF, Mdn (IQR) | 11.0 (9.0–13.0) | 12.0 (9.0–13.0) | 11.0 (9.0–13.0) | 0.26 | 9 |
MNA-SF score <8, n (%) | 62 (17.8) | 34 (16.7) | 28 (19.2) | 0.57 | 9 |
WHR, Mdn (IQR) | 0.91 (0.86–0.95) | 0.91 (0.85–0.96) | 0.91 (0.87–0.95) | 0.63 | 44 |
Waist circumference, m, Mdn (IQR) | 0.97 (0.87–1.07) | 0.98 (0.87–1.09) | 0.94 (0.85–1.04) | 0.04 | 37 |
Abdominal obesity, n (%) | 271 (84.4) | 166 (87.4) | 105 (80.2) | 0.09 | 37 |
OR | 95% CI | p | OR | 95% CI | p | OR | 95% CI | p | |
---|---|---|---|---|---|---|---|---|---|
MODEL 1 | MODEL 2 | MODEL 3 | |||||||
Chronic kidney disease | 2.40 | 1.3–4.1 | 0.003 | 2.30 | 1.3–4.0 | 0.004 | 2.27 | 1.3–4.1 | 0.006 |
Diabetes mellitus | 1.80 | 0.96–3.4 | 0.07 | 1.75 | 0.9–3.3 | 0.08 | 1.75 | 0.9–3.3 | 0.09 |
Procognitive medications | 0.48 | 0.2–1.1 | 0.08 | 0.37 | 0.1–0.99 | 0.048 | 0.37 | 0.14–0.99 | 0.049 |
Hypertension | 1.63 | 0.8–3.5 | 0.20 | 1.62 | 0.8–3.4 | 0.21 | 1.63 | 0.8–3.5 | 0.20 |
Ischemic heart disease | 1.12 | 0.6–1.99 | 0.69 | 1.12 | 0.6–1.99 | 0.70 | 1.11 | 0.6–1.98 | 0.72 |
Chronic cardiac failure | 0.90 | 0.5–1.6 | 0.73 | 0.93 | 0.5–1.7 | 0.81 | 0.92 | 0.5–1.7 | 0.78 |
Beta-blockers | 1.20 | 0.7–2.3 | 0.49 | 1.20 | 0.6–2.2 | 0.56 | 1.21 | 0.6–2.3 | 0.56 |
Statins | 1.02 | 0.6–1.8 | 0.95 | 1.02 | 0.6–1.8 | 0.95 | 1.02 | 0.6–1.8 | 0.96 |
SSRI | 0.80 | 0.4–1.5 | 0.50 | 0.79 | 0.4–1.5 | 0.49 | 0.80 | 0.4–1.5 | 0.50 |
Diuretics | 1.17 | 0.6–2.1 | 0.61 | 1.17 | 0.6–2.1 | 0.60 | 1.17 | 0.6–2.1 | 0.60 |
ACE-I or ARB | 0.91 | 0.5–1.8 | 0.78 | 0.93 | 0.5–1.8 | 0.83 | 0.93 | 0.5–1.8 | 0.84 |
Polypharmacy | 1.12 | 0.5–2.4 | 0.78 | 1.16 | 0.5–2.5 | 0.72 | 1.16 | 0.5–2.5 | 0.72 |
Abdominal obesity | 0.95 | 0.4–2.1 | 0.90 | 1.005 | 0.5–2.2 | 0.99 | 1.02 | 0.5–2.3 | 0.96 |
BMI > 30 kg/m2 | 1.13 | 0.6–2.1 | 0.69 | 1.12 | 0.6–2.0 | 0.72 | 1.13 | 0.6–2.1 | 0.71 |
Dementia | 1.41 | 0.7–2.8 | 0.33 | 1.39 | 0.7–2.8 | 0.36 | |||
Age | 1.01 | 0.96–1.05 | 0.84 | ||||||
Gender | 1.05 | 0.5–2.1 | 0.88 |
OR | 95% CI | p | |
---|---|---|---|
MODEL 4 | |||
Chronic kidney disease | 2.53 | 1.51–4.27 | <0.001 |
Diabetes mellitus | 1.9 | 1.04–3.44 | 0.04 |
Procognitive medications | 0.42 | 0.20–0.88 | 0.02 |
Hypertension | 1.75 | 0.91–3.34 | 0.09 |
© 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Wojszel, Z.B. Impending Low Intake Dehydration at Admission to A Geriatric Ward- Prevalence and Correlates in a Cross-Sectional Study. Nutrients 2020, 12, 398. https://doi.org/10.3390/nu12020398
Wojszel ZB. Impending Low Intake Dehydration at Admission to A Geriatric Ward- Prevalence and Correlates in a Cross-Sectional Study. Nutrients. 2020; 12(2):398. https://doi.org/10.3390/nu12020398
Chicago/Turabian StyleWojszel, Zyta Beata. 2020. "Impending Low Intake Dehydration at Admission to A Geriatric Ward- Prevalence and Correlates in a Cross-Sectional Study" Nutrients 12, no. 2: 398. https://doi.org/10.3390/nu12020398
APA StyleWojszel, Z. B. (2020). Impending Low Intake Dehydration at Admission to A Geriatric Ward- Prevalence and Correlates in a Cross-Sectional Study. Nutrients, 12(2), 398. https://doi.org/10.3390/nu12020398